GENNIEFY
Market News
Latest financial news and analysis from global markets
INTC
Prediction: Nvidia Will Reach a $10 Trillion Market Cap by 2028
The chipmaker's growth will drive it to previously unseen heights.
NVDA
Prediction: Nvidia Will Reach a $10 Trillion Market Cap by 2028
The chipmaker's growth will drive it to previously unseen heights.
V
Visa Targets AI Agents And European Merchants To Sustain Payments Role
Visa (NYSE:V) has launched its Agentic Ready program for AI driven payments, creating a pathway for agent initiated transactions within its Intelligent Commerce framework. The company has also entered into a collaboration with Ingenico to use the Visa Acceptance Platform to expand payment acceptance solutions and streamline certification for merchants across Europe. Visa is a global payments network that sits at the center of card based and digital transactions, connecting consumers,...
INTC
The SEC Just Handed XRP a Massive Win. Here's Why $3 Is Back On the Table.
This regulatory clarity matters a lot for a coin that's intended for use by risk-averse banks and financial institutions.
NVDA
The SEC Just Handed XRP a Massive Win. Here's Why $3 Is Back On the Table.
This regulatory clarity matters a lot for a coin that's intended for use by risk-averse banks and financial institutions.
ABNB
Meet the co-founder of Airbnb: How a weekend scheme to pay the rent turned into an industry giant
Airbnb was first dreamed up in 2008, with people initially asking “how could you trust a stranger ever in your own home?” In 2025, $92 billion was transacted on the platform. So how did they do it?View on euronews
MS
How The Investment Story For Waste Connections (WCN) Is Shifting With New Guidance And Cash Needs
The analyst fair value estimate for Waste Connections has adjusted slightly from US$198.75 to US$198.92, signaling only a very small tweak to the underlying valuation work. That kind of modest move fits with the latest research tone, where enthusiasm for the company’s business quality sits alongside fresh caution around 2026 guidance, project related spending, and recycled commodity pricing. As you read on, you will see how these cross currents are shaping the analyst narrative and what to...
MCD
McDonald's Value Push And Mario Tie In Versus Recent Share Weakness
McDonald's is introducing new U.S. menu items priced at $3 or less and $4 breakfast meal deals starting in April, aimed at cost conscious diners. The company is also rolling out a new Happy Meal collaboration with Nintendo's Mario franchise ahead of the Super Mario Galaxy Movie. Together, the value push and branded promotion are designed to support customer traffic and loyalty amid economic headwinds. For investors watching NYSE:MCD, these moves come at a time when the stock trades around...
CL
Colgate-Palmolive Taps Healthcare And Regional Marketing Expertise For Growth
Colgate-Palmolive (NYSE:CL) has appointed Dr. Christopher S. Boerner, CEO and Board Chair of Bristol Myers Squibb, to its Board of Directors. The company has also hired Hardik Jhaveri as senior director of marketing for its South Asean hub. For a consumer products company like Colgate-Palmolive, which is closely tied to global health, hygiene and personal care trends, these leadership changes sit at the intersection of healthcare expertise and regional execution. Investors watching large...
BMY
Colgate-Palmolive Taps Healthcare And Regional Marketing Expertise For Growth
Colgate-Palmolive (NYSE:CL) has appointed Dr. Christopher S. Boerner, CEO and Board Chair of Bristol Myers Squibb, to its Board of Directors. The company has also hired Hardik Jhaveri as senior director of marketing for its South Asean hub. For a consumer products company like Colgate-Palmolive, which is closely tied to global health, hygiene and personal care trends, these leadership changes sit at the intersection of healthcare expertise and regional execution. Investors watching large...
VRTX
How The Vertex Pharmaceuticals (VRTX) Story Is Shifting Toward Nephrology And Beyond Cystic Fibrosis
Vertex Pharmaceuticals now carries a fair value estimate of US$547.72, compared with the prior US$504.04, as analysts refresh their assumptions around the stock. Much of that shift is being tied to a stronger narrative around the company’s nephrology platform, recent povetacicept data in IgA nephropathy, and a cluster of price target lifts and rating upgrades. In the following sections, you will see how this evolving analyst story could matter for how you track Vertex and respond to future...
INTC
Where Will FMC Stock Be in 1 Year?
Don't underestimate FMC's rebound potential.